Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.414, 2003-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Use of -Blockers in Atrial Fibrillation
By Kühlkamp V. Bosch R. Mewis C. Seipel L.
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. :
Access to resources
Recommend
Valsartan reduces risk of atrial fibrillation in heart failure
Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. :
Ximelagatran reduces stroke risk in atrial fibrillation
Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. :
Barriers to warfarin use in atrial fibrillation
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :
Dronedarone: a guide to its use in atrial fibrillation
Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. :